We are live on ! Find out more
ALGN icon

Align Technology

149.71 USD
-0.74
0.49%
At close Updated Sep 17, 4:00 PM EDT
1 day
-0.49%
5 days
-2.34%
1 month
-12.53%
3 months
-13.73%
6 months
-15%
Year to date
-4.05%
1 year
15.66%
5 years
-79.19%
10 years
59.05%
 

About: Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Employees: 20,435

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 33.3%
Neutral 52.8%
Negative 13.9%
Neutral
Seeking Alpha
2 days ago
Align Technology, Inc. (ALGN) Presents at 2026 Global Healthcare Conference Transcript
Align Technology, Inc. (ALGN) Presents at 2026 Global Healthcare Conference Transcript
Align Technology, Inc. (ALGN) Presents at 2026 Global Healthcare Conference Transcript
Negative
Zacks Investment Research
3 days ago
Should You Continue to Hold ALGN Stock in Your Portfolio?
Align Technology expands Invisalign and digital dentistry adoption as iTero gains traction, but weak capital spending and currency volatility remain risks.
Should You Continue to Hold ALGN Stock in Your Portfolio?
Neutral
Business Wire
9 days ago
Align Technology to Speak at Upcoming Financial Conference
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following financial conference. The presentation will be webcast live via the Investor Relations section of Align's website at ht.
Align Technology to Speak at Upcoming Financial Conference
Neutral
Business Wire
17 days ago
Quentin Blackford to Join Align Technology Board of Directors
TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Quentin Blackford, President and Chief Executive Officer of iRhythm Technologies, as a director effective immediat.
Quentin Blackford to Join Align Technology Board of Directors
Negative
Zacks Investment Research
20 days ago
Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?
Negative
Zacks Investment Research
1 month ago
How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook
Align's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.
How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook
Negative
Zacks Investment Research
1 month ago
Should Investors Buy Align as Growth Meets Valuation and Demand Risks?
ALGN's record Clear Aligner growth and global adoption support the bull case, but demand softness and scanner pricing pressure keep investors cautious.
Should Investors Buy Align as Growth Meets Valuation and Demand Risks?
Neutral
Business Wire
1 month ago
Align Technology Prevails in China Patent Infringement Action Against Angelalign
SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China ("Angel") (Hong Kong Stock Exchange: 6699.HK). In September 2025, Align filed a.
Align Technology Prevails in China Patent Infringement Action Against Angelalign
Neutral
Seeking Alpha
1 month ago
Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple
Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows despite structural business improvements. Competitive pressures have eased post-SmileDirectClub exit, with ALGN retaining dominant market share and shifting growth toward international and DSO channels. Operating margins are expanding, management continues to raise guidance, and a robust buyback program is underway, supported by strong free cash flow.
Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple
Positive
Seeking Alpha
1 month ago
Align Technology: Attractively Valued But Growth Still Needs To Pick Up
Align Technology delivered record Q2 revenue and clear aligner volumes, with robust international growth offsetting North American stagnation. ALGN's strategy centers on expanding its digital dentistry platform, leveraging financing, lower-cost products, and ecosystem growth to drive recurring revenue. Valuation at $173 per share (15–16x forward earnings) is attractive for a market leader with high margins, net cash, and ongoing share buybacks.
Align Technology: Attractively Valued But Growth Still Needs To Pick Up
Price charts implemented using Lightweight Charts™